Dilated cardiomyopathy natural history, complications and prognosis: Difference between revisions
Created page with "{{Dilated cardiomyopathy}} {{CMG}} ==Overview== ==Prognosis== There are many prognostic factors which can be evaluated in a patient with dilated cardiomyopathy.<ref> Mayo ..." |
No edit summary |
||
Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Overview== | ==Overview== | ||
Line 15: | Line 17: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] |
Revision as of 17:14, 23 August 2012
Dilated cardiomyopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Dilated cardiomyopathy natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Dilated cardiomyopathy natural history, complications and prognosis |
FDA on Dilated cardiomyopathy natural history, complications and prognosis |
CDC on Dilated cardiomyopathy natural history, complications and prognosis |
Dilated cardiomyopathy natural history, complications and prognosis in the news |
Blogs on Dilated cardiomyopathy natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Prognosis
There are many prognostic factors which can be evaluated in a patient with dilated cardiomyopathy.[1] The most important prognostic indicator is a decreased ejection fraction, in addition increased left ventricular size and right ventricular dilation are independent indicators of a poor prognosis.
As is in most types of heart failure a poor NYHA functional class and increased PASP (>35mmHg) are also poor prognostic indicators.
Other findings that infer a poor prognosis are as follows: Maximal O2 uptake of < 12mL/kg / minute on exercise testing, LBBB (left bundle branch block), non sustained ventricular tachycardia, syncope, hyponatremia with a serum sodium less than 135, elevated norepinephrine, ANP (atrial natriuretic peptide) and renin levels (not routinely measured in clinical practice), elevated PCWP (pulmonary capillary wedge pressure) > 18mmHg, low cardiac index < 2.5L/min/m^2.
References
- ↑ Mayo Clinic Cardiology. Concise Textbook. Murphy, Joseph G; Lloyd, Margaret A. Mayo Clinic Scientific Press. 2007.